Physician profile
Juan M Class
NPI 1992086599
$951.61
in general payments reported to CMS, 2019-2025
8 companies · $932 in 2025
The $932 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $19.72 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $951.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $218.25 | 2025 | Barrigel |
| Photocure INC | $156.19 | 2025 | Cysview |
| Integra Lifesciences Corporation | $150.19 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Procept Biorobotics Corporation | $146.82 | 2025 | |
| Boston Scientific Corporation | $135.15 | 2025 | General - Kidney Stone Disease, Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $107.17 | 2025 | Gemtesa |
| Masimo Corporation | $19.72 | 2024 | Sedline |
| Urogen Pharma, INC. | $18.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Class listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.